Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,08
KB2,75
PKN71,9471,952,98
Msft436,53436,7-0,37
Nokia4,374,520,65
IBM249,24249,36-1,89
Mercedes-Benz Group AG50,9350,950,39
PFE22,4322,44-2,33
09.05.2025 18:14:53
Indexy online
AD Index online
select
AD Index online
 

  • 09.05.2025 18:04:16
CorVel (CRVL.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
113,16 0,84 0,94 25 247
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 09.05.2025
Popis společnosti
Obecné informace
Název společnostiCorVel Corp
TickerCRVL
Kmenové akcie:Ordinary Shares
RICCRVL.O
ISIN-
Poslední známé roční výsledky31.03.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.03.2024 4 870
Akcie v oběhu k 03.02.2025 51 359 138
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice2010 Main Stree, Suite 1020
MěstoIRVINE
PSČ92614
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon19 498 511 473
Fax19498511469

Business Summary: CorVel Corporation applies technology including artificial intelligence, machine learning and natural language processing to enhance the management of episodes of care and the related health care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies in managing workers' compensation and health, auto and liability services. Its customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients. The Company's services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. The Company offers a complete medical savings solution for all in-network and out-of-network medical bills. Its bill review services include coding review and re-bundling, reasonable and customary review, fee schedule analysis, preferred provider organization management, and repricing.
Financial Summary: BRIEF: For the nine months ended 31 December 2024, CorVel Corp revenues increased 13% to $664.1M. Net income increased 21% to $68.7M. Revenues reflect Patient management Services segment increase of 11% to $432.2M, Network Solution Services segment increase of 17% to $231.9M, United States segment increase from $202.3M to $664.1M. Net income benefited from United States segment income increase from $22.4M to $87.5M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Healthcare Facilities & Services (NEC)
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSAll Other Miscellaneous Ambulatory Health Care Services
NAICSResidential Mental Health and Substance Abuse Facilities
NAICSClaims Adjusting
NAICSPharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds
NAICSAll Other Insurance Related Activities
NAICS2007All Oth Misc Ambulatory Health Care Services
NAICS2007Residential Mental Health and Substance Abuse Facilities
NAICS2007Claims Adjusting
NAICS2007Insurance & Pension Funds, Third Party Admin
NAICS2007All Other Insurance Related Activities
NAICS1997All Other Miscellaneous Ambulatory Health Care Services
NAICS1997Residential Mental Health and Substance Abuse Facilities
NAICS1997Claims Adjusters
NAICS1997Third Party Administration for Insurance and Pension Funds
NAICS1997All Other Insurance Related Activities
SICInsurance Agents/brokers/service
SICHealth And Allied Services, Nec
SICResidential Care
SICInsurance Agents/brokers/service
SICPension/health/welfare Funds



  • Poslední aktualizace: 09.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerMichael Combs6026.11.202430.04.2015
Chief Financial OfficerBrandon O'Brien4401.10.201801.10.2018
Executive Vice President - Risk Management ServicesMark Bertels6101.04.202201.04.2022
Executive Vice President - ProductSarah Scott-13.02.202513.02.2025
Chief Information OfficerMaxim Shishin4901.01.2017
Vice President - AccountingJennifer Yoss4601.10.2018
SecretaryRichard Schweppe6828.05.2019